Evaluation of FAS2-ELISA for the serological detection of Fasciola hepatica infection in humans

111Citations
Citations of this article
82Readers
Mendeley users who have this article in their library.

Abstract

The performance of Fas2-ELISA for the diagnosis of Fasciola hepatica infection in children living in areas of high endemicity for fascioliasis in the Peruvian Andes is analyzed. Fas2-ELISA is based on the detection of circulating IgG antibodies elicited in infected individuals against a F. hepatica antigen termed Fas2. The study was conducted in three Andean localities, Huertas-Julcan in Junin, Asillo in Puno, and Cajamarca, with a total population of 634 children in an age range 1 to 16 years old. Child fascioliasis prevalence was 21.1% in Huertas-Julcan, 25.4% in Asillo, and 24% in Cajamarca, estimated by coprological inspection. The seroprevalence of F. hepatica infection, determined by Fas2-ELISA, was 27.8% in Huertas-Julcan, 44.6% in Asillo, and 29.1% in Cajamarca. The overall sensitivity of Fas2-ELISA was 92.4%, the specificity 83.6%, and the negative predictive value 97.2%. No association between OD 450 Fas2-ELISA and infection intensity measured by egg counting was observed. Results show that Fas2-ELISA is a highly sensitive immunodiagnostic test for the detection of F. hepatica infection in children living in human fascioliasis endemic areas. Copyright © 2007 by The American Society of Tropical Medicine and Hygiene.

Cite

CITATION STYLE

APA

Espinoza, J. R., Maco, V., Marcos, L., Saez, S., Neyra, V., Terashima, A., … Mas-Coma, S. (2007). Evaluation of FAS2-ELISA for the serological detection of Fasciola hepatica infection in humans. American Journal of Tropical Medicine and Hygiene, 76(5), 977–982. https://doi.org/10.4269/ajtmh.2007.76.977

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free